Clinical trials: Neurotypical

Fragile X Syndrome (FXS), Neurotypical Adults

Neural Biomarkers in Fragile X Syndrome

• Completed
• Age: 18 to 55 years
• Observational study

The purpose of this non-interventional test /re-test study is to assess neural biomarkers in adult subjects with Fragile X syndrome compared to those measured in a population of typically developing adults

Trial name

EXP-CTH120 (NCT06957054)

Testing

Any

Where

2 sites in Spain

Volunteers

20 people, healthy volunteers welcome

Sponsor

Connecta Therapeutics, S.L.